经动脉化疗栓塞术使用载药微球时镰状动脉非靶栓塞导致的皮肤坏死
Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads.
作者信息
Smith Mitchell T, Johnson David Thor, Gipson Matthew G
机构信息
Department of Radiology, University of Colorado, Aurora, Colorado.
出版信息
Semin Intervent Radiol. 2015 Mar;32(1):22-5. doi: 10.1055/s-0034-1396960.
Abstract
Intra-arterial embolic therapies are a mainstay of liver-directed therapies to palliate symptoms, improve survival, and bridge patients to transplantation. Vascular anatomy and type of embolic used can lead to complications of nontarget embolization with varying clinical consequences. This case report describes a rare, nontarget embolization of the falciform artery leading to supraumbilical skin necrosis.
摘要
动脉内栓塞治疗是肝脏定向治疗的主要手段，用于缓解症状、提高生存率以及为患者移植做准备。血管解剖结构和所用栓塞剂的类型可能导致非靶栓塞并发症，产生不同的临床后果。本病例报告描述了一例罕见的镰状韧带动脉非靶栓塞导致脐上皮肤坏死的情况。
相似文献
1
Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads.
Semin Intervent Radiol. 2015 Mar;32(1):22-5. doi: 10.1055/s-0034-1396960.
2
Acute pancreatitis after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads.
Semin Intervent Radiol. 2015 Mar;32(1):18-21. doi: 10.1055/s-0034-1396959.
3
Transarterial Chemoembolization-Induced Ischemic Colitis: A Rare Complication Due to Nontarget Embolization.
ACG Case Rep J. 2023 Sep 23;10(9):e01140. doi: 10.14309/crj.0000000000001140. eCollection 2023 Sep.
4
Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma.
Cardiovasc Intervent Radiol. 1995 May-Jun;18(3):183-5. doi: 10.1007/BF00204147.
5
Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.
J Vasc Interv Radiol. 2010 Mar;21(3):327-32. doi: 10.1016/j.jvir.2009.10.038. Epub 2010 Jan 22.
6
Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.
J Ultrasound Med. 2015 May;34(5):859-67. doi: 10.7863/ultra.34.5.859.
7
Skin ischemia and ulceration as a complication of inferior phrenic artery embolization for hepatocellular carcinoma.
Radiol Case Rep. 2018 Apr 5;13(3):648-651. doi: 10.1016/j.radcr.2018.02.032. eCollection 2018 Jun.
8
Nontarget embolization complicating transarterial chemoembolization in a patient with hepatocellular carcinoma.
Semin Intervent Radiol. 2011 Jun;28(2):202-6. doi: 10.1055/s-0031-1280665.
9
Imaging Validation of Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinomas in Living Donor Liver Transplantation.
Transplant Proc. 2018 Nov;50(9):2622-2625. doi: 10.1016/j.transproceed.2018.05.012. Epub 2018 May 24.
10
[Reexamination of hepatic falciform artery: angiographic study].
Nihon Igaku Hoshasen Gakkai Zasshi. 1999 Mar;59(4):131-6.
引用本文的文献
1
Rash and subcutaneous fat necrosis after DEB-TACE with doxorubicin.
BMJ Case Rep. 2018 Jan 5;2018:bcr-2017-222394. doi: 10.1136/bcr-2017-222394.
2
Abdominal Skin Rash After TACE Due to Non-Target Embolization of Hepatic Falciform Artery.
ACG Case Rep J. 2016 Apr 15;3(3):217-20. doi: 10.14309/crj.2016.55. eCollection 2016 Apr.
本文引用的文献
1
Supraumbilical subcutaneous fat necrosis after transcatheter arterial chemoembolization with drug-eluting beads: case report and review of the literature.
Cardiovasc Intervent Radiol. 2013 Feb;36(1):276-9. doi: 10.1007/s00270-012-0356-6. Epub 2012 Mar 2.
2
A case of hepatocellular carcinoma with skin injury of the upper abdominal wall after transcatheter arterial chemoembolization: a case report.
Cases J. 2009 Sep 1;2:7197. doi: 10.4076/1757-1626-2-7197.
3
Fatal ischemic acute pancreatitis complicating trans-catheter arterial embolization of small hepatocellular carcinoma: do the risks outweigh the benefits?
J Hepatol. 2008 Jul;49(1):149-52. doi: 10.1016/j.jhep.2008.02.021. Epub 2008 May 16.
4
Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.
J Vasc Interv Radiol. 2007 Apr;18(4):553-61; quiz 562. doi: 10.1016/j.jvir.2007.02.002.
5
Angiographic considerations in patients undergoing liver-directed therapy.
J Vasc Interv Radiol. 2005 Jul;16(7):911-35. doi: 10.1097/01.RVI.0000164324.79242.B2.
6
Supraumbilical skin rash and fat necrosis after transcatheter arterial chemoembolization: a case report.
Kaohsiung J Med Sci. 2004 Jan;20(1):36-40. doi: 10.1016/S1607-551X(09)70082-8.
7
Hepatic falciform artery: angiographic observations and significance.
Abdom Imaging. 2001 Sep-Oct;26(5):515-9. doi: 10.1007/s002610000207.
8
Hepatic falciform artery. Angiographic findings in 25 patients.
Acta Radiol. 2000 Jul;41(4):329-33. doi: 10.1080/028418500127345596.
9
Supraumbilical dermal sclerosis and fat necrosis from chemoembolization of hepatocellular carcinoma.
J Vasc Interv Radiol. 1998 Jul-Aug;9(4):645-7. doi: 10.1016/s1051-0443(98)70336-7.
10
In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors.
J Vasc Interv Radiol. 1993 Nov-Dec;4(6):741-7. doi: 10.1016/s1051-0443(93)71965-x.
Zotero 插件